dnth103
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 23, 2024 (NCT06282159)
Timeline
Indications
Mechanism of action
- Complement C1sINHIBITOR
C1S inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06858579 | Phase 3 | Feb 10, 2025 | Dianthus Therapeutics |
| NCT06537999 | Phase 2 | Sep 17, 2024 | Dianthus Therapeutics |
| NCT06282159 | Phase 2 | Feb 23, 2024 | Dianthus Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dianthus Therapeutics | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1